Nidhi Kudur, DO
Adolescent Medicine · San Antonio, TXNPI 1487008777
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Novo Nordisk accounts for 70.9% of it on its own, with 7 other manufacturers making up the rest.
Across 38 payments — averaging $26.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$711
- AbbVie$86
- Lilly USA, LLC$59
- GSK$58
- Sanofi$29
- Xeris Pharmaceuticals, Inc.$24
- plus $37 from 2 others
What the payments were for
- Food & beverage$1,002100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $711 |
| AbbVie | 4 | $86 |
| Lilly USA, LLC | 3 | $59 |
| GSK | 3 | $58 |
| Sanofi | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Merck | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$238
How this compares
$1,002 in reported general payments places this provider in the 65th percentile of 68 adolescent medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 79 | $2,251 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,104 |
| Atorvastatin Calcium | 95 | $921 |
| Omeprazole | 49 | $850 |
| Duloxetine Hcl | 15 | $660 |
| Metoprolol Succinate | 32 | $629 |
| Potassium Chloride | 13 | $504 |
| Escitalopram Oxalate | 38 | $458 |
| Gabapentin | 32 | $453 |
| Pantoprazole Sodium | 35 | $448 |
| Fluticasone Propionate | 21 | $442 |
| Amlodipine Besylate | 67 | $434 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 23 | $424 |
| Rosuvastatin Calcium | 34 | $399 |
| Sertraline Hcl | 53 | $371 |
Paid to pharmacies, not to this prescriber.
Other adolescent medicine in San Antonio
- Gabriel PerezSan Antonio$1K
- Louanne WellfordSan Antonio$64
- Andres HernandezSan Antonio$55
- Joan PurcellThe Woodlands$87K
- Amy MiddlemanHouston$70K
- Augustine ElejeEl Paso$37K
- Richard RuppGalveston$20K
- Scott SpearEdinburg$11K
- Marcy BerryPlano$7K
- Marlo BrawnerLivingston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.